Sotuvning sof marjinal rentabelligi: Twist Bioscience (TWST)

TWST (Twist Bioscience) - kompaniyaning tovar belgisi

Twist Bioscience (TWST) dori vositalarini kashf qilish va ma'lumotlarni saqlash uchun texnologik gigantlar hamda biotexnologiya sektori bilan hamkorlikni rivojlantirmoqda. Sof foyda marjasi ushbu strategiyaning samaradorligini tasdiqlaydi, bunda -28.30 qiymati ushbu holatni aks ettiradi. Sintetik biologiya sohasining ushbu yetakchisi ulkan ambitsiyali madaniyati va RSUlar orqali eng yaxshi muhandislarni jalb qilmoqda. Yopiq B2B ekotizimi platformaning qulayligi va tezligi tufayli mijozlarning yuz foizligini saqlab qolishni ta'minlaydi.

Twist Bioscience Corp (TWST) Sotuvning sof rentabelligi: 04.07.2022 - 19.11.2026 davri uchun

Twist Bioscience kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning fundamental baholanishi:Twist Bioscience Inc, TWST
Twist Bioscience Corp yetakchi tovari

Twist Bioscience kompaniyasining ma'lumotlarni saqlash va agritech segmentlariga diversifikatsiyasi har bir dollar daromadning sof foyda ulushini barqarorlashtirishi kerak. Sof marjalardagi o'zgarishlarni tahlil qilish orqali investor biznesning inflyatsiyaviy zarbalar va foiz stavkalariga moslashish tezligini baholaydi, bunda grafikdagi keskin tebranishlar operatsion samaradorlikning beqarorligi va kapitalning to'satdan yo'qolishi xavflaridan signal beradi.

Asosiy raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TXG (10x Genomics) - Sof foyda bo'yicha sotuv rentabelligi|Intellia Therapeutics, Inc. (NTLA) - Sotuvning sof marjinal rentabelligi|Sof marja Stoke Therapeutics Inc|BLFS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi WVE (Wave Life Sciences Corp)|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX